,LRRK2

Verena Dederer1, Marta Sanz Murillo2, Eva P Karasmanis3

  • 1Institute of Pharmaceutical Chemistry, Goethe-Universität, Frankfurt, Germany; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Goethe-Universität, Frankfurt, Germany; Aligning Science Across Parkinson's (ASAP), Chevy Chase, Maryland, USA.

概括

研究人员开发了E11,一种新的蛋白质结合剂,用于氨酸丰富的重复激酶2 (LRRK2). 该工具针对WD40领域,为帕金森病机制和药物开发提供了新的见解.